In major diabetes research news just published in Nature Communications, scientists at the Diabetes Research Institute (DRI) at the University of Miami have shown that a small peptide, called THR-123, ...

Q: I have been caring for my 75-year-old husband with dementia for the past four years (I am 72), and I’m at my wits’ end.

Background and Purpose— Complement components are emerging risk factors for cardiovascular disease. In this study, we examined the relation among C3, C-reactive protein (CRP), factor B, and features ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of ...